Allergan Defeats Whistleblower's Bid to Revive Fraud Suit (1)
A whistleblower lost his bid to reinstate a False Claims Act suit alleging that Allergan Inc. and Adamas Pharmaceuticals Inc. fraudulently obtained patents on two drugs to combat Alzheimer’s disease.
Dermabrasion Market Expected To Reach USD 1125.16 Million By 2032, Growing At CAGR 7.62% To Forecast 2024-2032
Allergan Aesthetics Launches Innovative SkinMedica® Acne Solutions to Combat Skin Blemishes with Advanced <a target=_blank href= ...
Allergan Aesthetics launches new AA Signature Program at IMCAS 2025 to redefine patient-centric, multimodal treatment plans
In response to growing demand for personalized, patient-centric aesthetic solutions1,2, Allergan Aesthetics, an AbbVie Company, is proud to unveil the new AA Signature program, an innovative approach ...